6--16-- COMBINATION OF A 6-OXO-16-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR

N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물. A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-...

Full description

Saved in:
Bibliographic Details
Main Authors BLADT FRIEDHELM, FRIESE HAMIM MANJA
Format Patent
LanguageEnglish
Korean
Published 07.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물. A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide.
AbstractList N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 또는 이의 약학적으로 허용 가능한 염 및/또는 용매화물의 약학적 조성물. A pharmaceutical composition of 3-(1-{3-[5-(1-Methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof in combination with N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide.
Author BLADT FRIEDHELM
FRIESE HAMIM MANJA
Author_xml – fullname: BLADT FRIEDHELM
– fullname: FRIESE HAMIM MANJA
BookMark eNqNyr0KwjAUhuEOOvh3DwecA_GHSsfTJG0OYiIhVOtSisRJ2mK9f4zgBTh8fMPzzpNJ13dhlrxSxjZxIOwpJ4OerAFbAELK7NV-TZKupbPsXDuSeCOjQCpHVWwrBRorMiWg8cQEGqEcoIhCvoYLeR0FVFk4IKMpJ2_dMpk-2ucYVr9fJOtCeaFZGPomjEN7D114N0e35ZsD5xnfZxnu_qs-xUo58Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate EGFR 억제제와 항암 활성을 갖는 6-옥소-1,6-디히드로-피리다진 유도체의 조합
ExternalDocumentID KR20170090499A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20170090499A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20170090499A3
Notes Application Number: KR20177018885
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170807&DB=EPODOC&CC=KR&NR=20170090499A
ParticipantIDs epo_espacenet_KR20170090499A
PublicationCentury 2000
PublicationDate 20170807
PublicationDateYYYYMMDD 2017-08-07
PublicationDate_xml – month: 08
  year: 2017
  text: 20170807
  day: 07
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies MERCK PATENT GMBH
RelatedCompanies_xml – name: MERCK PATENT GMBH
Score 3.0607648
Snippet N-[3-[[2-[4-(4-아세틸피페라진-1-일)-2-메톡시-아닐리노]-5-(트리플루오로메틸)피리미딘-4-일]아미노]페닐]프로프-2-엔아미드와 조합된, 3-(1-{3-[5-(1-메틸-피페리딘-4-일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title 6--16-- COMBINATION OF A 6-OXO-16-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH AN EGFR INHIBITOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170807&DB=EPODOC&locale=&CC=KR&NR=20170090499A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMMwp6ptOxY8pAaVvwa72Y30o0jbtGseaEWrdfBlrm4Eo29gq_n2TbtM97SGQ5EJIDi53l_sC4EHVc9syxhxlbdVAulGoKJsUHGlaYWgWn3C7inLtxWb0qr8MjEENfG1iYao8oT9VckRBUbmg97J6r-f_n1i48q1cPmYfYmr2HCYOVtbaccsSApClYM8J-hRTX_F9p8uUmK1gqi0FfHcP7AtB2pL0EKSejEuZbzOV8AQc9MV-0_IU1D5nDXDkb2qvNcBhb23yFt019S3PwMJEqCUa9GnPI6s8tpCG0IUmogMqYZhEQ8wo6g8Zwe47iQOIhaqWirVpACM3JXEHunFCkC-r0jAonUhSkgzhG0kiAYFBJ2SQxBHxSELZObgPg8SPkDj86A9Xoy7bvunTBahPZ1N-CaBg89zMMt2Wtkyu5nZhtXO10AuN83xsFFeguWun693gG3Ash5VnnNUE9XLxzW8Fty6zuwrJv_dQjn8
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8QjXhT1PiB2kSzW-OY-2AHYrZ1YxW2kWZO8ELYVhKjAQIz_vu2A5QThyZNf81L2-T1vdf3UQAeZDUzDW3MUNqSNaRquYzSSc6QouSaYrAJM8ss1yDU_Vf1ZaANKuBrkwtT1gn9KYsjco7KOL8X5X09_3_EwmVs5fIx_eBDs2cvbmNpbR03Da4AGRK2224_wpEjOU67S6WQrjDZFAq-tQf2uZJtCH5wE1vkpcy3hYp3DA76nN60OAGVz1kd1JzN32t1cBisXd68u-a-5SlY6Ag1eYNOFNhkVccWRh60oI6iQSQwTPwhphHqDynB1jsJXYi5qZbwuYkLfSshYQdaYUyQI36loVAEkSQkHsI3EvscgW7Ho5CEPrFJHNEzcO-5seMjvvjR31mNunR7p0_noDqdTdkFgFzMMz1NVVP4MpmcmbnRyuRczRXGsrGWX4LGLkpXu-E7UPPjoDfqkbB7DY4EVEbJGQ1QLRbf7IZL7iK9LQ_8F9NckXI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=6--16--+COMBINATION+OF+A+6-OXO-16-DIHYDRO-PYRIDAZINE+DERIVATIVE+HAVING+ANTI-CANCER+ACTIVITY+WITH+AN+EGFR+INHIBITOR&rft.inventor=BLADT+FRIEDHELM&rft.inventor=FRIESE+HAMIM+MANJA&rft.date=2017-08-07&rft.externalDBID=A&rft.externalDocID=KR20170090499A